The observations that RAGE plays roles in diet-induced obesity and NAFLD have important implications for the development of insulin and glucose intolerance, thereby bringing roles for the RAGE pathway in cardiometabolic dysfunction to full circle. The gene discussed is AGER; the disease is metabolic dysfunction-associated steatotic liver disease.